Appeal No. 1998-1245
Application No. 08/111,831
10. A method for treating psychosis, comprising administering an effective
dosage of at least one lipoxygenase metabolite of docosahexaenoic acid or derivative
thereof.
11. The method according to Claim 10, wherein the lipoxygenase metabolite or
derivative thereof is selected from the group consisting of 14-hydroxydocosahexaenoic
acid, ethyl 14-hydroxydocosahexaenoate, 7-hydroxydocosahexaenoic acid or ethyl 7-
hydroxydocosahexaenoate.
12. A method for treating psychosis, comprising administering an effective
dosage of at least one P450 dehydrogenase metabolite of docosahexaenoic acid or
derivative thereof.
13. The method according to Claim 12, wherein the P450 dehydrogenase
metabolite or derivative thereof is selected from the group consisting of 7, 8-
epoxydocosapentaenoic acid or ethyl 7, 8-epoxydocosapentaenoate.
14. A method for treating psychosis, comprising administering an effective
dosage of a composition consisting essentially of a phospholipid or triglyceride of
docosahexaenoic acid.
The references relied upon by the examiner are:
Kimura et al. (Kimura I), “Use of docosahexaenoic acid for improving brain function,”
Chemical Abstracts, Abstract No. 112:191978p (1990)
Horrobin et al (Horrobin), “Essential fatty acid composition for treating schizophrenia and
inflammatory skin disorders,” Chemical Abstracts, Abstract No. 113:158684n (1990)
Kimura et al. (Kimura II), “Pharmaceutical and food compositions containing
docosahexaenoic acid derivatives for improvement of brain functions,” Chemical
Abstracts, Abstract No. 113:71343b (1990)
Goodman and Gilman's (Goodman and Gilman's), The Pharmacological Basis of
Therapeutics, (6th Ed.), page 12 (1980)
VanRollins et al. (VanRollins I), "Oxidation of docosahexaenoic acid by rat liver
microsomes," HCAPLUS, Abstract No. 1984:41994 (1984)
2
Page: Previous 1 2 3 4 5 6 7 8 9 10 11 12 Next
Last modified: November 3, 2007